IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
Article in International Immunopharmacology (June 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (June 2024)
Article in Acta Pharmacologica Sinica (June 2024)
Article in Biomedicine & Pharmacotherapy (April 2024)